Predicting Cost‐Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United States-Reference-Cited by-同舟云学术

Predicting Cost‐Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United States

Published:2020-02-13 Issue:2 Volume:13 Page:352-361
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Wang Ching‐Yu¹,Pham Phuong N.¹,Kim Sarah²^ORCID,Lingineni Karthik²,Schmidt Stephan²,Diaby Vakaramoko¹,Brown Joshua¹^ORCID

Affiliation:

1. Department of Pharmaceutical Outcomes and Policy Center for Drug Evaluation & Safety University of Florida College of Pharmacy Gainesville Florida USA

2. Department of Pharmaceutics Center for Pharmacometrics and Systems Pharmacology University of Florida College of Pharmacy Orlando Florida USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12719

Reference35 articles.

1. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2. Management of Atrial Fibrillation

3. Atrial fibrillation: Current understandings and research imperatives

4. Management of paroxysmal atrial fibrillation

5. Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of DOACs in frail elderly patients in light of class genericization;International Journal of Cardiology;2024-09

2. A comparative in vitro study of the anticoagulant effect of branded versus generic rivaroxaban;Thrombosis Research;2024-01

3. Use of Doacs in Frail Elderly Patients in Light of Class Genericization;2024

4. Methods for Economic Evaluations of Novel Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review;Applied Health Economics and Health Policy;2023-10-29

5. Linked Pharmacometric‐Pharmacoeconomic Modeling and Simulation in Clinical Drug Development;Clinical Pharmacology & Therapeutics;2020-10-26